March 28, 2014 article Open access Desensitization protocol should not be used in acute lymphoblastic leukemia patients with silent inactivation of PEGasparaginase Haematologica DOI: 10.3324/haematol.2013.099663 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 4 stored of 19 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Comment on “Multiple reactions during desensitization may predict decreased efficacy of PEGasparaginase chemotherapy” 2024 Annals of Allergy Asthma & Immunology article Medicine Drug-Induced Adverse Reactions 1 citations Comment on: Desensitization using PEGasparaginase in the era of commercially available Erwinia: A single‐institution report on efficacy, cost, and resource utilization 2024 Pediatric Blood & Cancer letter Medicine Drug-Induced Adverse Reactions 0 citations Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial 2024 Journal of Clinical Oncology article Medicine Acute Lymphoblastic Leukemia research Open access 12 citations Comment on Ammonia level as a proxy of asparaginase inactivation in children: A strategy for classification of infusion reactions 2021 Journal of Oncology Pharmacy Practice article Medicine Drug-Induced Adverse Reactions Open access 4 citations 4 results References 0